Inflammatory profiles in older people with and without HIV in rural Uganda
- PMID: 41176722
- DOI: 10.1111/hiv.70097
Inflammatory profiles in older people with and without HIV in rural Uganda
Abstract
Introduction: Although the risk of chronic inflammation among people living with HIV is well established in younger individuals, it is less well understood whether these relationships are persistent in older people living with HIV with long-term virologic suppression. Such data are particularly sparse in sub-Saharan Africa.
Methods: We assessed five inflammatory biomarkers (hs-CRP, sCD14, sCD163, D-dimer and FABP-2) among 290 older (antiretroviral therapy) ART-treated people living with HIV and an age-similar cohort of people without HIV in rural Uganda. We fit linear and logistic multivariable regression models with each biomarker as the outcome of interest, HIV serostatus as the primary exposure of interest, and age and sex as secondary exposures. Interaction terms between HIV and either age or sex were also explored.
Results: Among 591 participants, 49% (n = 290) were people living with HIV and 49% (n = 290) were women, the median age was 57 years (interquartile range 53-61). Adjusted linear analyses showed that people living with HIV had higher levels of sCD163 (β = 0.307, p < 0.001), D-dimer (β = 0.223, p < 0.01), and FABP-2 (β = 0.627, p < 0.001) than people without HIV. However, HIV did not modify relationships between increasing age and inflammation. In sub-analyses, we found that people living with HIV had lower levels of hs-CRP with each additional 10 years of age (β = -0.231, p < 0.01) and that women had higher D-dimer (p = 0.01), lower hs-CRP (p < 0.01) and greater increases in sCD163 with increasing age (β = 0.276, p < 0.01) than men.
Conclusion: Although older people living with HIV in Uganda tend to have higher biomarkers of inflammation than people without HIV, these differences appear to be stable with increasing age. Notably, older women with and without HIV tended to have higher levels of sCD163, which were exacerbated with increasing age.
Keywords: HIV/AIDS; aging; immune activation; inflammation; sub‐Saharan Africa.
© 2025 British HIV Association.
References
REFERENCES
-
- Wallis ZK, Williams KC. Monocytes in HIV and SIV infection and aging: implications for inflamm‐aging and accelerated aging. Viruses. 2022;14(2):409.
-
- North CM, Allen JG, Okello S, et al. HIV infection, pulmonary tuberculosis, and COPD in rural Uganda: a cross‐sectional study. Lung. 2018;196(1):49‐57. doi:10.1007/s00408‐017‐0080‐8
-
- Brown TT, Moser C, Currier JS, et al. Changes in bone mineral density after initiation of antiretroviral treatment with Tenofovir Disoproxil fumarate/Emtricitabine plus Atazanavir/ritonavir, Darunavir/ritonavir, or Raltegravir. J Infect Dis. 2015;212(8):1241‐1249. doi:10.1093/infdis/jiv194
-
- Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. Association between systemic inflammation and incident diabetes in HIV‐infected patients after initiation of antiretroviral therapy. Diabetes Care. 2010;33(10):2244‐2249. doi:10.2337/dc10‐0633
-
- Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of Functional Impairment with inflammation and immune activation in HIV type 1–infected adults receiving effective antiretroviral therapy. J Infect Dis. 2013;208(2):249‐259. doi:10.1093/infdis/jit147
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
